Transcriptomics

Dataset Information

0

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease [Naïve]


ABSTRACT: Chronic graft-versus-host disease (cGVHD) remains the leading cause of non-relapse morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Effective therapeutics agents targeting dysregulated cytokines including IL-17 and CSF-1 have been defined in preclinical models of cGVHD, and efficacy in subsequent clinical trials has led to their recent FDA approval. Despite this, these agents are effective in only a subset of patients, expensive, difficult to access outside the US, and used in a trial-and-error fashion. The ability to readily discern druggable, dysregulated immunity in these patients is desperately needed to facilitate the selection of appropriate treatment and to potentially identify high-risk individuals for preemptive therapy. We used single cell sequencing-based approaches in our informative preclinical cGVHD models to “reverse engineer” temporal IL-17 and CSF-1 signatures in mouse blood that could be used to interrogate patients. We defined distinct, non-intuitive IL-17 and CSF-1 signatures in mouse blood monocytes that could be identified in relevant monocytes within 70% of patients at diagnosis of cGVHD and in half of patients at day +100 post-HCT who subsequently developed cGVHD. These signatures can now be evaluated prospectively in clinical studies to help delineate potential responder and non-responders to relevant therapeutics targeting these pathways.

ORGANISM(S): Mus musculus

PROVIDER: GSE287420 | GEO | 2025/06/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-06-01 | GSE287419 | GEO
2025-06-01 | GSE287415 | GEO
2016-05-27 | PXD002762 | Pride
2013-07-11 | E-GEOD-23924 | biostudies-arrayexpress
2013-07-11 | GSE23924 | GEO
2023-11-14 | GSE216645 | GEO
| PRJNA1212730 | ENA
| PRJNA1212725 | ENA
2023-02-22 | GSE200520 | GEO
2024-12-02 | GSE269610 | GEO